News Quantified

DTIL – precision biosciences, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy [Yahoo! Finance]

Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy

iECURE Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ECUR-506 for Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 [Seeking Alpha]

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

-10.2%

MISS

-8.6%

MISS

-8.3%

MISS

-15.5%

MISS

Form 8-K PRECISION BIOSCIENCES For: Jan 12

Form EFFECT PRECISION BIOSCIENCES

Form S-3 PRECISION BIOSCIENCES

Form S-8 PRECISION BIOSCIENCES

Form 4 PRECISION BIOSCIENCES For: Dec 16 Filed by: Germano Geno J

Top News Gainers

11/13 Precision BioSciences Inc (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock. 24.6%

4/6 Form 8-K PRECISION BIOSCIENCES For: Apr 06 21.4%

11/6 Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting 18.6%

1/8 Form 4 PRECISION BIOSCIENCES For: Jan 06 Filed by: ANSARI ABID 17.3%

3/12 Form 3 PRECISION BIOSCIENCES For: Mar 10 Filed by: Germano Geno J 13.8%

4/28 Precision BioSciences Announces Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting 6.8%

4/8 Precision BioSciences Inc (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock. 6.4%

11/12 Form 10-Q PRECISION BIOSCIENCES For: Sep 30 5.7%

2/24 Precision BioSciences: Consider Taking Up A Small Position [Seeking Alpha] 5.4%

11/13 Form 3 PRECISION BIOSCIENCES For: Nov 08 Filed by: Buehler Kevin 5.3%

Top News Decliners

12/9 Precision BioSciences stock rises on early-stage CAR-T trial data [MarketWatch] -54.5%

3/12 Form 8-K PRECISION BIOSCIENCES For: Mar 12 -16.5%

4/15 Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources -16.4%

8/9 Precision BioSciences Inc (NASDAQ: DTIL) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock. -16.3%

4/2 Precision BioSciences Inc (NASDAQ: DTIL) was downgraded by analysts at Goldman Sachs Group Inc from a "buy" rating to a "neutral" rating. -15.9%

3/11 Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano -14.6%

1/15 Form 8-K/A PRECISION BIOSCIENCES For: Jan 15 -12.4%

1/13 Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma -8.0%

9/25 Form 4 PRECISION BIOSCIENCES For: Sep 23 Filed by: KANE MATTHEW R. -7.7%

2/7 Form SC 13G PRECISION BIOSCIENCES Filed by: BlackRock Inc. -7.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day